Stock Screener App

Gratuito -

Installare

17.18

2.51% 0.42

First Tracks Biotherapeutics Inc (TRAX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Sahm

Zumiez Inc. to Report Fiscal 2026 First Quarter Results - The Manila Times

First Tracks Biotherapeutics (TRAX) Stock Forecast and Price Target 2026 $TRAX - MarketBeat

TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

First Tracks Biotherapeutics, Inc.Ordinary Shares (NQ: TRAX - FinancialContent

AnaptysBio (ANAB) Valuation After Spin Off And Shift To Royalty Focused Model - Sahm

First Tracks Biotherapeutics (NASDAQ: TRAX) registers 10.5M resale shares; issuer gets no proceeds - Stock Titan

Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway - TipRanks

TRAX SEC FilingsFirst Tracks Biotherapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Form 424B3 First Tracks Biotherapeu - StreetInsider

First Tracks Biotherapeutics (NASDAQ: TRAX) registers 10.5M resale shares - Stock Titan

First Tracks Biotherapeutics 1Q 2026: Net loss $(50.5M), Revenue $0— 10-Q Summary - TradingView

[Form 4] First Tracks Biotherapeutics, Inc. Insider Trading Activity - Stock Titan

First Tracks Biotherapeutics (NASDAQ: TRAX) details Q1 loss and major post spin-off cash raises - Stock Titan

First Tracks Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - The Manila Times

[8-K] First Tracks Biotherapeutics, Inc. Reports Material Event - Stock Titan

Director at First Tracks Bio (NASDAQ: TRAX) receives new equity awards - Stock Titan

Director Magda Marquet granted options and RSUs at First Tracks (TRAX) - Stock Titan

Director at First Tracks Biotherapeutics (TRAX) granted options and RSUs - Stock Titan

Director John A. Orwin receives new equity awards at First Tracks Biotherapeutics (TRAX) - Stock Titan

First Tracks (TRAX) awards director 42,000 options and 15,000 RSUs - Stock Titan

Executive equity awards at First Tracks Biotherapeutics (TRAX) detailed - Stock Titan

First Tracks (TRAX) CEO receives new stock options and RSU awards - Stock Titan

First Tracks Biotherapeutics (TRAX) CFO receives new option and RSU awards - Stock Titan

First Tracks Biotherapeutics, Inc. (TRAX) Cash From Financing (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Dividend (TTM) - Zacks Investment Research

This First Tracks Biotherapeutics analyst begins coverage on a bullish note; here are top 4 initiations for Monday - MSN

[EFFECT] First Tracks Biotherapeutics, Inc. SEC Filing - Stock Titan

Is AnaptysBio (ANAB) 51.9% Undervalued After Q1 2026 EPS/Revenue - GuruFocus

TRAX Should I Buy - Intellectia AI

AnaptysBio (NASDAQ: ANAB) shifts to royalty focus after Q1 2026 loss - Stock Titan

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance

First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research

Two new option listings and one option delisting on May 11th - TipRanks

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

First Tracks Biotherapeutics, Inc. (TRAX) Cash From Operations (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Net Income (TTM) - Zacks Investment Research

TRAX: First Tracks Biotherapeutics, Inc.Interactive Chart - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Eps Diluted (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Ps Ratio (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Debt Equity Ratio (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Return On Equity (TTM) - Zacks Investment Research

First Tracks Biotherapeutics Stock Slides After Investors Move to Sell 10 Million Shares - Moomoo

Stocks to Watch: Kestrel Group, First Tracks Biotherapeutics, Inhibrx Biosciences - Moomoo

TRAX Insider Trading (First Tracks Biotherapeutics Inc stock) - StockInvest.us

First Tracks Biotherapeutics Inc Stock Data and SignalsTRAX - StockInvest.us

According to a document submitted to the U.S. Securities and Exchange Commission, existing selling shareholders of First Tracks Biotherapeutics Inc may sell up to 10.5 million shares of the company’s common stock. - Bitget

First Tracks Biotherapeuticsselling stockholders may sell up to 10.5 shares of common stockSEC filing - marketscreener.com

First Tracks Biotherapeutics, Inc. (TRAX) Dividend Yield (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Return On Assets (TTM) - Zacks Investment Research

TRAX Technical Analysis & Stock Price Forecast - Intellectia AI

First Tracks Biotherapeutics, Inc. (TRAX) Price Book Value - Zacks Investment Research

AnaptysBio rises after completing First Tracks spinoff - msn.com

First Tracks (TRAX) Stock Analysis Report | Financials & Insights - Benzinga

TRAX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

TRAX News & Events - Intellectia AI

TRAX Forecast — Price Prediction for 2026. Should I Buy TRAX? - Intellectia AI

TRAX PE Ratio & Valuation, Is TRAX Overvalued - Intellectia AI

ROIV

$29.96

2.98%

INSM

$106.24

3.00%

BNTX

$92.14

1.33%

RPRX

$54.50

1.77%

ONC

$310.25

0.20%

RVMD

$151.56

1.41%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters